MTOR and non-small cell lung carcinoma: Additionally, aberrant activation of the PI3K/Akt/mTOR pathway in NSCLC enhances PD-L1 protein translation, while PD-L1 overexpression reciprocally activates PI3K/Akt/mTOR signaling (49).